Vice President, Innovation

The Vice President Innovation and New Product Development is part of the Global Oncology Therapeutic Area Leadership Team, responsible as the clinical referent in the expansion of the oncology pipeline by the evaluation of new business development opportunities, coordinating the Clinical Development Plan (CDP) of new oncology asset(s) in partnership with Global Project Teams. This position:

- Recognized as influential leader, develops, proposes, and influences project and R&D teams on new uses for compounds currently in proof of concept and/or life cycle management.
- Delivers high-quality medical/scientific/strategic input on external innovation and business development opportunities.
- Establish and lead the CDP for the new oncology assets including but not limited participation to due diligence, assets acquisition and to support regional and/or global drug development.
- Works closely in partnership with global oncology teams: External Innovation, Business Development, Early Development, Regulatory Affairs, Drug Safety, Medical Affairs, legal and commercial Franchise Oncology in providing clinical support for drug development programs.
- Consistently works within complex medical situations under tight time constraints, prioritizing appropriately to deliver expected results.

Main responsibilities and tasks

**Core Remit of Activities Internal to Therapeutic Area Development (approx. 75%)**
- Serves as the Clinical referent for the evaluation of business development opportunities from early triage, due diligence to asset licensing/acquisition.
- Participate with TA Head and other senior managers in establishing and presenting Clinical Development strategic plans within senior governance meetings.
- Supports the integration of new licensed/acquired asset in all clinical, scientific, strategic matters both at study team and asset team levels from lead compound identification to product registration and LCM.
- Contribute to and/or prepare CDP, and clinical trial related documents, including but not limited to Investigator Brochure, communication with regulatory authorities, clinical trial synopses, clinical trial protocols, clinical summaries, Clinical Study Report, with the support of other R&D functions and in line with Integrated Development Plan (IDP).
- Establish and maintain professional relationships with external medical experts and key thought leaders and to represent Ipsen R&D Oncology TA at investigator meetings, advisory boards, scientific conference or alike.

**Core Remit of Activities External to Therapeutic Area Development (approx. 35%)**
- Proactively liaise with Global Drug Discovery to ensure scientific and medical integrity of Integrated Development Plans (IDP), TPP etc.
- Liaise with key internal experts as required to support pre-clinical programs and Project Teams for most efficient development of new chemical entities.
- Liaise with Early Clinical Development platform and Clinical Pharmacology department to provide medical expertise to Early Development programs (up to and including proof-of-concept studies).

**General duties and responsibilities**
- Comply with Ipsen’s SOPs, GCP, governmental policies, regulations, statutory guidelines and applicable laws regulating drug development and clinical research.
- Develop and maintain state of the art scientific, medical and managerial knowledge by:

- Establishing and maintaining an external professional network
- Reading pertinent scientific and medical publications
- Attending pertinent training courses, workshops, conferences etc.
- Commit to support transformation and change management of R&D division with a focus on high performance culture, data quality, timeliness and budget control accounts.
- Assume tasks within the context of team performance and project progress in an objective-driven, solution and results oriented manner with an overall can-do attitude.
- Be a proactive member and contributor to Ipsen’s medical community.

Experience / Qualifications
- Medical Doctor (MD)
- Minimum 15 years’ proven experience in oncology development area (from pre-clinical to registration)
- Significant experience of assessing novel solid tumors and hematologic malignancies
- Substantial scientific and academic experience (preferably with clinical trial experience); with state-of-the-art medical, scientific knowledge; and track record of successful publications
- Substantial experience in pharmaceutical drug development and, in industry context, track record of global clinical trials management
- Previous experience directly and independently leading projects and/or a team of professionals
- Previous experience on transversal projects (with other functions) and multiple therapeutic areas and stages of drug development, exhibiting the ability to influence others (above and beyond ones’ own function)